Trump Administration to Announce Autism Findings Tied to Acetaminophen, Possible New Treatment

The Trump administration is expected to make an announcement today regarding new findings on autism. Over the weekend, the president previewed the development, telling reporters he believed acetaminophen — the active ingredient in Tylenol — plays a significant role in autism risk.

The comment comes despite a recent study that found no direct tie between acetaminophen use during pregnancy and autism. However, The Wall Street Journal reported earlier this month that administration officials have been reviewing a range of studies on the subject. Among them is an August review by researchers at Mount Sinai and Harvard, which suggested a possible link between acetaminophen use early in pregnancy and an increased autism risk in children.

In addition to those findings, today’s announcement is expected to include new details about Leucovorin, a lesser-known drug being studied as a potential treatment for autism. Researchers have been exploring its use in addressing metabolic issues that may affect children with autism spectrum disorder.

The upcoming announcement is likely to spark debate in the medical community, where questions remain over the quality of evidence linking acetaminophen to autism. Many experts emphasize that additional research is necessary to confirm or rule out any potential connection.

Explore: NBCPalmSprings.com, where we are connecting the Valley.